Dr. Cwik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3300 E Sunrise Dr
Tucson, AZ 85718Phone+1 520-529-5496Fax+1 520-529-5454- Is this information wrong?
Education & Training
- Cleveland Clinic FoundationResidency, Neurology, 1989 - 1990
- University of Illinois College of Medicine at ChicagoResidency, Neurology, 1986 - 1989
- University of Illinois College of Medicine at RockfordInternship, Transitional Year, 1985 - 1986
- Rush Medical College of Rush University Medical CenterClass of 1985
Certifications & Licensure
- AZ State Medical License 1996 - 2019
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 18 citationsFair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trialsArthur L. Caplan, J. Russell Teagarden, Lisa Kearns, Alison Bateman-House, Edith P. Mitchell, Thalia Arawi, Ross E.G. Upshur, Ilina Singh, Joanna Różyńska, Valerie Cwi...> ;Journal of Medical Ethics. 2018 Jul 7
- 99 citationsEfficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophyRobert C. Griggs, J. Phillip Miller, Cheryl R. Greenberg, Darcy Fehlings, Alan Pestronk, Jerry R. Mendell, Richard T. Moxley, Wendy C. King, John T. Kissel, Valerie Cw...> ;Neurology. 2016 Nov 15
- 17 citationsClinical Follow‐Up for Duchenne Muscular Dystrophy Newborn Screening: A ProposalJennifer M. Kwon, Hoda Abdel-Hamid, Samiah Al-Zaidy, Jerry R. Mendell, Annie Kennedy, Kathi Kinnett, Valerie Cwik, Natalie Street, Julie Bolen, John W. Day, Anne M. Co...> ;Muscle & Nerve. 2016 Jun 13
- Join now to see all
Press Mentions
- Young Boy’s Struggle to Survive Sparked Push for Drugs for Terminally IllOctober 3rd, 2016
- FDA Approves First Drug to Treat Rare Form of Muscular DystrophySeptember 19th, 2016
- Muscular Dystrophy Association to Collaborate with Catabasis Pharmaceuticals on Development of CAT-1004, a Potential Novel Oral Disease-Modifying Treatment for Duchenne Muscular DystrophyFebruary 5th, 2016
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: